Parallax Volatility Advisers’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Parallax Volatility Advisers’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,800	Closed	-$70.8K	–	2739
2023 Q2	$70.8K	Buy	+1,800	New	+$63.5K	﹤0.01%	2039
2022 Q4	–	Sell	-5,300	Closed	-$95K	–	3414
2022 Q3	$95K	Buy	+5,300	New	+$69.6K	﹤0.01%	2487
2017 Q1	–	Sell	-21,900	Closed	-$106K	–	4887
2016 Q4	$106K	Hold	21,900	–	–	﹤0.01%	2174
2016 Q3	$1.01M	Sell	21,900 -2,100	-9%	-$118K	﹤0.01%	1250
2016 Q2	$1.23M	Buy	+24,000	New	+$1.19M	﹤0.01%	1114

Parallax Volatility Advisers's ISEE Position: Q2 2023 in Review

Parallax Volatility Advisers sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 48 shares — an estimated $1.69K sold.

Parallax Volatility Advisers first reported a position in ISEE in Q2 2016 and held it in 5 quarters. The position peaked at $982K in Q2 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

Parallax Volatility Advisers reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Parallax Volatility Advisers sold 48 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $1.69K.
Parallax Volatility Advisers first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 5 quarters.
Parallax Volatility Advisers's IVERIC bio, Inc. Common Stock position peaked at $982K in Q2 2022.
256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Parallax Volatility Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.